Status | Study |
Not yet recruiting |
Study Name: A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma Condition: Allergic Bronchopulmonary Aspergilloses Date: 2017-04-21 Interventions: Drug: Glucocorticoids Oral pre |
Recruiting |
Study Name: Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter Study Condition: Chronic Pulmonary Aspergillosis Date: 2017-01-14 |
Recruiting |
Study Name: A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis Condition: Allergic Bronchopulmonary Aspergillosis Date: 2015-05-01 Interventions: Drug: Itraconazole Oral itraco |
Enrolling by invitation |
Study Name: Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). Condition: Allergic Bronchopulmonary Aspergillosis Date: 2014-10-22 Interventions: Drug: Liposomal amphotericin B (Ambisome®) |
Recruiting |
Study Name: Voriconazole for IPA in Chinese Patients With COPD Condition: Invasive Pulmonary Aspergillosis COPD Date: 2014-09-02 Interventions: Drug: Voriconazole 2-week long intravenous instillation of voriconazole |
Active, not recruiting |
Study Name: CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients Condition: Invasive Pulmonary Aspergillosis Date: 2014-03-03 Interventions: Drug: Voriconazole Patients with creatinine clearance at least 50 ml/min will be treated with voriconazo |
Recruiting |
Study Name: Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study Condition: Invasive Pulmonary Aspergillosis Date: 2014-01-20 Interventions: Device: Lateral Flow Device Test Testing of leftover BAL samples from clinical routine by the lateral fl |
Completed |
Study Name: Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients Condition: Survival After IPA Risk Factors for IPA Date: 2013-05-27 |
Completed |
Study Name: A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis Condition: Allergic Bronchopulmonary Aspergillosis Date: 2013-05-13 Interventions: Drug: Inhaled budesonide The c |
Active, not recruiting |
Study Name: Protocol TARC-ABPA Condition: Allergic Broncho-Pulmonary Aspergillosis Date: 2012-10-15 Interventions: Other: Study of predictive factors Phase 1 : Inclusion of |